Search Results - "Koerper, M A"

Factor V deficiency: a concise review by HUANG, J. N., KOERPER, M. A.

“…Factor V (FV; proaccelerin or labile factor) is the plasma cofactor for the prothrombinase complex that activates prothrombin to thrombin. FV deficiency can be…”
Get full text

Complications of haemophilia in babies (first two years of life): a report from the Centers for Disease Control and Prevention Universal Data Collection System by Kulkarni, R., Presley, R. J., Lusher, J. M., Shapiro, A. D., Gill, J. C., Manco‐Johnson, M., Koerper, M. A., Abshire, T. C., DiMichele, D., Hoots, W. K., Mathew, P., Nugent, D. J., Geraghty, S., Evatt, B. L., Soucie, J. M.

“…Aim To describe the prevalence and complications in babies ≤2 years with haemophilia. Methods We used a standardized collection tool to obtain consented data…”
Get full text

Increasing mixed chimerism and the risk of graft loss in children undergoing allogeneic hematopoietic stem cell transplantation for non-malignant disorders by Ozyurek, E, Cowan, M J, Koerper, M A, Baxter-Lowe, L-A, Dvorak, C C, Horn, B N

“…We performed quantitative PCR-based serial chimerism testing of whole blood (WB) and CD3 + cells and retrospectively correlated the results of chimerism tests…”
Get full text

Utilization of care in haemophilia: a resource-based method for cost analysis from the Haemophilia Utilization Group Study (HUGS) by Globe, D. R., Curtis, R. G., Koerper, M. A.

“…The Haemophilia Utilization Group Study (HUGS) was created 10 years ago to examine the annual utilization and cost of haemophilia‐related healthcare services…”
Get full text

Quality of life in haemophilia A: Hemophilia Utilization Group Study Va (HUGS-Va) by POON, J.-L., ZHOU, Z.-Y., DOCTOR, J. N., WU, J., ULLMAN, M. M., ROSS, C., RISKE, B., PARISH, K. L., LOU, M., KOERPER, M. A., GWADRY-SRIDHAR, F., FORSBERG, A. D., CURTIS, R. G., JOHNSON, K. A.

“…This study describes health‐related quality of life (HRQoL) of persons with haemophilia A in the United States (US) and determines associations between…”
Get full text

MASAC Consensus Conference: impediments to conducting clinical research in persons with haemophilia, von Willebrand's disease and rare bleeding disorders by Koerper, M. A., Frick, N., Kessler, C. M.

“…Summary A consensus conference conducted by the Medical and Scientific Advisory Council of the National Hemophilia Foundation was held in New Orleans, LA, on…”
Get full text

Factor IX inhibitors and anaphylaxis in hemophilia B by WARRIER, I, EWENSTEIN, B. M, KATZ, J, BERGMANN, F, LJUNG, R, PETRINI, P, LUSHER, J. M, KOERPER, M. A, SHAPIRO, A, KEY, N, DIMICHELE, D, MILLER, R. T, PASI, J, RIVARD, G. E, SOMMER, S. S

“…We present clinical and laboratory data on 18 children from 12 hemophilia treatment centers in the United States, Canada, and Europe with the purpose of…”
Get full text

Perioperative Management of von Willebrand's Disease in Otolaryngologic Surgery by Shah, Saurabh B., Lalwani, Anil K., Koerper, Marion A.

“…von Willebrand's disease (VWD) is the most common hereditary bleeding disorder. Unchecked or improperly managed, VWD‐associated hemorrhage can lead to…”
Get full text

Renal transplantation without chronic immunosuppression after T cell-depleted, HLA-mismatched bone marrow transplantation by Sorof, J M, Koerper, M A, Portale, A A, Potter, D, DeSantes, K, Cowan, M

Get more information

Germline origins in the human F9 gene : frequent G:C→A:T mosaicism and increased mutations with advanced maternal age by KETTERLING, R. P, VIELHABER, E, GRUPPO, R, AMBRIZ, R, PAREDES, R, SOMMER, S. S, XUEMIN LI, DROST, J, SCHAID, D. J, KASPER, C. K, PHILLIPS, J. A, KOERPER, M. A, KIM, H, SEXAUER, C

“…The factor IX gene (F9) is an advantageous system for analyzing recent spontaneous germline mutation in humans. Herein, the male:female ratio of mutation ("r")…”
Get full text

Magnetic resonance imaging of transfusional hemosiderosis complicating thalassemia major by Brasch, R C, Wesbey, G E, Gooding, C A, Koerper, M A

“…Tissue deposits of hemosiderin, a paramagnetic iron-protein complex, resulted in marked abnormalities of magnetic resonance (MR) spin-echo signal intensity…”
Get more information

Safety and immunogenicity of subcutaneous hepatitis A vaccine in children with Haemophilia by Ragni, Lusher, Koerper, Manco-Johnson, Krause

“…Individuals with Haemophilia are at risk from hepatitis A virus (HAV) infection through exposure to blood products. Havrix®, an intramuscular hepatitis A…”
Get full text

One course versus two courses of antithymocyte globulin for the treatment of severe aplastic anemia in children by MATLOUB, Y. H, SMITH, C, MOERTEL, C. L, MONTH, S, MONTELEONE, P, RAMSAY, N. K. C, BOSTROM, B, KOERPER, M. A, O'LEARY, M, KHUDER, S, SMITHSON, W. A, NICKERSON, H. J, SILBERMAN, T, HILDEN, J

“…The aim of the therapeutic trials was to optimize the treatment of severe aplastic anemia (SAA) and moderate aplastic anemia in children who lack a suitable…”
Get full text

Anaphylactic response to factor IX replacement therapy in haemophilia B patients: complete gene deletions confer the highest risk by Thorland, E C, Drost, J B, Lusher, J M, Warrier, I, Shapiro, A, Koerper, M A, Dimichele, D, Westman, J, Key, N S, Sommer, S S

“…Haemophilia B is an X-linked recessive coagulopathy due to mutations in the factor IX gene. Occasionally, patients receiving factor IX replacement therapy…”
Get full text

Intramural duodenal hematoma after endoscopic biopsy in leukemic patients by Lipson, Scott A., Perr, Hilary A., Koerper, Marion A., Ostroff, James W., Snyder, John D., Goldstein, Ruth B.

Get full text

Risk of human immunodeficiency virus type 1 infection among sexual and nonsexual household contacts of persons with congenital clotting disorders by LUSHER, KJ. M, OPERSKALSKI, E. A, ADEDORT, L. M, DIETRICH, S. L, GJERSET, G. F, HILGARTNER, M. W, KOERPER, M. A, PEGELOW, C. H, HANG LEE, MOSLEY, J. W

“…The status of human immunodeficiency virus type 1 (HIV-1) infection at the time of transmission to sexual contacts remains poorly defined. Transmission to…”
Get full text

Genetic mutations in ten unrelated American patients with symptomatic type 1 protein C deficiency by Tsay, W, Greengard, J S, Montgomery, R R, McPherson, R A, Fucci, J C, Koerper, M A, Coughlin, J, Griffin, J H

“…Symptomatic patients with Type 1 protein C deficiency and venous thrombosis were analysed for defects in this gene using polymerase chain reaction…”
Get more information

Germline mutations in the factor IX gene: a comparison of the pattern in Caucasians and non-Caucasians by Gostout, B, Vielhaber, E, Ketterling, R P, Yoon, H S, Bottema, C D, Kasper, C K, Koerper, M A, Sommer, S S

“…DNA samples of patients from around the world have been sequenced to precisely define the mutations in the factor IX gene resulting in hemophilia B. This study…”
Get more information

Transmission of hepatitis C virus by monoclonal-purified viral-attenuated factor VIII concentrate by Kessler, C, Lusher, J, Pierce, G F, Pierce, B, Koerper, M A, Dickinson, J C

Get more information

Anaphylactic response to factor IX replacement therapy in haemophilia B patients: complete gene deletions confer the highest risk by THORLAND, E. C., DROST, J. B., LUSHER, J. M., WARRIER, I., SHAPIRO, A., KOERPER, M. A., DIMICHELE, D., WESTMAN, J., KEY, N. S., SOMMER, S. S.

“…Haemophilia B is an X‐linked recessive coagulopathy due to mutations in the factor IX gene. Occasionally, patients receiving factor IX replacement therapy…”
Get full text